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INTRODUCTION
Although previously published studies have documented
a high perioperative risk in patients with liver failure under-
going general surgery, such as, elective abdominal surgery
(1-4), thoracotomy (5), and trauma operations (6, 7), little
information is available on clinical outcomes following ortho-
pedic surgery in this group of patients. Ziser et al. (8), in their
retrospective review of 733 cirrhotic patients undergoing any
type of surgical procedure, reported that patients undergo-
ing major orthopedic procedures including hip surgery, spine
fusions, and operations for long bone fractures had a substan-
tially higher perioperative complication rate than patients
undergoing non-orthopedic surgery.
Whilst elective total hip arthroplasty (THA) is generally
regarded as safe, with an associated perioperative mortality
rate of less than 1% in the general population (9-11), data
are extremely limited on the safety and outcome of hip arthro-
plasty in patients with advanced liver disease. Only two recent
studies (12, 13), to the best of our knowledge, have evaluat-
ed the perioperative risks of hip arthroplasty in cirrhotic pati-
ents. The purpose of this study was to document periopera-
tive morbidity and mortality in patients with liver cirrhosis
undergoing hip arthroplasty.
MATERIALS AND METHODS
We retrospectively reviewed the complete medical records
of 30 cirrhotic patients who had undergone hip arthroplasty
at three participating academic institutions between Octo-
ber 1994 and May 2001. Cirrhosis was diagnosed primarily
by biopsy, and when biopsy was not performed, abdominal
ultrasonography or computed tomography was used for the
diagnosis of cirrhosis, in conjunction with a history of liver
disease and abnormal liver function test results. There were
26 males and 4 females with a mean age of 60 yr (range, 15-
63 yr) at the time of index operation. The procedures included
17 primary THAs, 8 bipolar hemiarthroplasties, and 5 revi-
sion THAs. Of the 25 primary hip arthroplasties, the diag-
noses leading to surgery were osteonecrosis of the femoral
head in 13, hip fracture in 10, and osteoarthritis in 2.
Preoperative data included age, gender, levels of serum
albumin, total bilirubin and creatinine, the presence of ascites,
esophageal varices, or encephalopathy, and prothrombin time.
A modification of the Child’s classification by Pugh (14) was
used as a measure of liver dysfunction. The severity of cirrhosis
was graded as class A when the Child-Pugh score was 5 or 6
points, class B from 7 to 9, and class C from 10 to 15 (a higher
score indicates more severe cirrhosis). Perioperative compli-
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Perioperative Risk of Hip Arthroplasty in Patients with Cirrhotic Liver
Disease
We retrospectively reviewed the complete medical records of 30 patients with a diag-
nosis of liver cirrhosis who had undergone hip arthroplasty at three academic insti-
tutions between October 1994 and May 2001. There were 26 males and 4 females
with a mean age of 60 yr at index operation. Surgical procedures included 17 primary
total hip arthroplasties (THA), 8 bipolar hemiarthroplasties, and 5 revision THAs.
According to the Child-Pugh scoring system, 19 cirrhotic patients were categorized
as class A, 9 as class B, and 2 as class C. Eight (26.7%) of the 30 patients had one
or more perioperative complications. Of these, wound infection was the most com-
mon, with a rate of 10% (3 of 30 hips). Other perioperative complications included
surgical site bleeding, coagulopathy, encephalopathy, gastrointestinal bleeding, pneu-
monia, and arrhythmia. Death occurred in 2 (6.7%) of the 30 patients; both were
Child-Pugh’s C cirrhotics. A higher Child-Pugh score (p=0.0001) and a high level
of creatinine (p=0.0499) were associated with significantly increased perioperative
complications or death. Our findings suggest that surgeons should be vigilant about
perioperative complications in patients with advanced cirrhotic liver disease who
undergo hip arthroplasty, albeit the mortality rates are relatively low in less severe
cirrhotics.
Key Words : Hip Arthroplasty; Liver Cirrhosis; Perioperative Complications; Risk Factors
Received : 2 February 2006
Accepted : 25 August 2006224 Y.-W. Moon, Y.-S. Kim, S.-Y. Kwon, et al.
cations searched for were as follows: postoperative bleeding
(gastrointestinal or surgical site), coagulopathy, wound (dehis-
cence or infection), encephalopathy, cardiovascular (conges-
tive heart failure, myocardial infarction, or arrhythmia), pul-
monary (pneumonia, pulmonary embolism, or ventilatory
dependence), renal (acute tubular necrosis, hepatorenal syn-
drome, or ascites), and infection (bacteremia or fungemia).
Postoperative bleeding was defined as hemorrhage requiring
transfusion, and gastrointestinal and surgical site bleedings
were distinguished from each other based on a review of the
medical records. Coagulopathy (whether on the basis of reduc-
ed hepatic synthesis, disseminated intravascular coagulation,
normal consumption, or dilutional mechanisms) was noted
in those patients with a decreased platelet count, fibrinogen
concentration, and increased activated partial thromboplas-
tin time. New onset or worsening of ascites or encephalopa-
thy was also registered as a postoperative complication within
30 days of hip arthroplasty. Mortality was defined as death
within 30 days of index arthroplasty. We chose this 30-day
perioperative time limit because a shorter period may have
missed complications and deaths directly related to events
that had begun during hip surgery or hospitalization.
Twelve variables were investigated to determine risk fac-
tors in liver cirrhosis patients who underwent hip arthroplas-
ty; age, gender, the presence of ascites or varices, prothrom-
bin time, the levels of albumin, bilirubin, and creatinine, the
type of surgery (primary THA, bipolar hemiarthroplasty, or
revision THA), the type of anesthesia (general or spinal), opera-
tion time, and estimated operative blood loss. As none had
a preoperative encephalopathy, it was excluded from the inves-
tigation.
Statistical analysis was performed using the SAS statisti-
cal software package (SAS Institute, Cary, NC, U.S.A.). Mul-
tivariate logistic regression models were used to identify fac-
tors differentiating complicated and uncomplicated hip arth-
roplasties in cirrhotic patients. Generalized estimating equa-
tions were used to control for the clustering of complications
within patients. Variables deemed significant by multivari-
ate analysis at p<0.05 were considered risk factors associated
with perioperative morbidity and mortality in liver cirrho-
sis patients who underment hip arthroplasty.
RESULTS
According to assessments of liver cirrhosis severity using
the Child-Pugh scoring system, 19 patients (63.3%) were
class A, 9 (30.0%) class B, and 2 (6.7%) were class C.
Eight (26.7%) of the 30 patients had one or more periop-
erative complications. Of these, a superficial wound infec-
tion was the most common, with a rate of 10% (3 of 30 hips).
Other postoperative complications included 2 surgical site
bleedings, 2 coagulopathies, 2 encephalopathies, 1 gastroin-
testinal bleeding, 1 pneumonia, and 1 arrhythmia. In the
analysis of the cirrhotic patients by individual Child-Pugh’s
class, perioperative complications occurred in 1 (5.3%) of
19 class A cirrhotics, 5 (55.6%) of 9 class B, and 2 (100%)
of 2 class C (Table 1). Two patients with class C died from aspi-
ration pneumonia and disseminated intravascular coagula-
tion, respectively, during the first postoperative month. Thus,
the perioperative mortality rate was 6.7% (2 of 30 patients).
Of the twelve variables that were investigated to identify
risk factors for complicated hip arthroplasty in patients with
liver cirrhosis, a high level of creatinine was solely associated
with increased perioperative mortality (p=0.0499). No sta-
tistically significant associations were found in the other vari-
ables including age, gender, the presence of ascites or varices,
prothrombin time, the levels of albumin and bilirubin, the
type of surgery, the type of anesthesia, operation time, and
*Some patients were associated with more than one complications.
Child-Pugh classification
ABC
Total number of patients 19 9 2
Complications (no. of occurrences)*
Wound infection 0 3 0
Operative site bleeding 0 1 1
Coagulopathy 1 0 1
Encephalopathy 1 0 1
GI bleeding 0 1 0
Pneumonia 0 0 1
Arrythmia 0 1 0
Total number (%) of patients with  1 (5.3) 5 (55.6) 2 (100)
any complications
Table 1. Perioperative complications following hip arthroplasty











Presence of ascites 0.0513 0.0574
Presence of varices 0.6536 0.119
Prothrombin time 0.3564 0.0979
Albumin level 0.0921 0.0947
Bilirubin level 0.9736 0.095
Creatinine level 0.1313 0.0499
Type of surgery
Primary THA vs. BHA 0.7723 0.5546
Primary THA vs. revision THA 0.8127 0.2823
Operation time 0.2734 0.5794
Estimated operative blood loss 0.7123 0.4
Type of anesthesia 0.9672 0.627
Table 2. Variables associated with perioperative complications
and death following hip arthroplasty in cirrhotic patients
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estimated operative blood loss. However, combining all of
the categories included in the Child-Pugh scoring system, a
significantly increased risk of perioperative complications was
noted in cirrhotic patients who had a higher Child-Pugh score
(p=0.0001) (Table 2).
DISCUSSION
Previous studies (1-7, 15-18) have well documented high
rates of perioperative complications in patients with liver
failure undergoing anesthesia and surgery, especially those
undergoing major orthopedic procedures (8). However, data
are extremely limited on the safety and outcome of hip or knee
arthroplasty in patients with advanced liver disease (12, 13,
19). Ziser et al. (8) evaluated 733 patients with a diagnosis
of liver cirrhosis who had undergone some type of surgical
procedure, and reported a perioperative complication rate of
30.1% and a mortality rate of 11.6% within 30 days of sur-
gery. Of these, 26 procedures were hip and pelvic surgery,
arthroplasty, or fractures, and this subgroup showed a sub-
stantially increased perioperative complication rate of 53.8%.
Recently, Hsieh et al. (13) reported on the outcomes of 45
hip arthroplasties that had been performed over a period of
20 yr in 38 patients with liver cirrhosis, with a perioperative
30-day complication rate of 26.7%. They found that advanced
cirrhotics (Child-Pugh’s B and C patients) had a higher risk
of complications than Child-Pugh’s A cirrhotics (p=0.004).
Cohen et al. (12) also reported a 20.7% major complication
rate for cirrhotic patients who received either total hip or knee
arthroplasty. In accordance with these previous studies, we
observed a high perioperative complication rate (26.7%, 8
of 30) in cirrhotic patients that had undergone hip arthro-
plasty. Of the twelve variables evaluated in our series, a high
level of creatinine was found to be the only risk factor asso-
ciated with perioperative mortality. However, combining
all of the categories included in the Child-Pugh scoring sys-
tem, a higher Child-Pugh score was another important risk
factor of perioperative morbidity. Our findings were also con-
sistent with the previous observations that there was a trend
toward an increased perioperative risk for hip arthoplasty in
cirrhotic patients with more advanced liver disease.
Rice et al. (16) reported a mortality rate within 30 days
of surgery of 28% for patients with chronic liver failure who
had undergone non-hepatic surgery, and that 2 of 5 patients
who underwent unspecified orthopedic surgery died. Hsieh
et al. (13) reported that 18 of 38 cirrhotic patients undergo-
ing hip arthroplasty died during the protracted study peri-
od of 20 yr. Of these, 8 patients died from complications of
liver cirrhosis. Cohen et al. (12) reported a 10.3% perioper-
ative mortality rate for cirrhotic patients who received either
total hip or knee arthroplasty, and this mortality rate increased
to 15.8% (3 of 19) in cirrhotic THA patients. However, a
relatively lower rate of perioperative mortality (6.7%, 2 of
30) was noted in the present study as compared with previous
series that enrolled patients with liver cirrhosis undergoing
orthopedic surgery over a long time span. Although it may
be attributed to the small number of patients with severe liver
cirrhosis (Child-Pugh’s class C) in our series, we believe that
the improvement of medical care of cirrhotic patients and
refinement in surgical techniques that have occurred during
past decade may contribute to the lower mortality rate. Cohen
et al. (12) also suggested that less extensive operative proce-
dures, such as bipolar hemiarthroplasty, would be associated
with more favorable outcomes than those of primary or revi-
sion THAs, but our findings showed no statistically signifi-
cant difference among the different surgical procedures, which
we attribute to the small sample size.
In conclusion, we continue to perform hip arthroplasty in
patients with cirrhotic liver disease, but we should warn pa-
tients with a higher Child-Pugh score and those with an in-
creased creatinine level about their increased perioperative
risk of complications or death. Cirrhotic patients should be
aware that they are at increased risk for surgical complica-
tions because of their disease, albeit the mortality rates are
relatively low in less severe cirrhotics. 
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